Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Journal of Travel Medicine|September 8, 2021
TaqMan Array Card testing of participant-collected stool smears to determine the pathogen-specific epidemiology of travellers' diarrhoea†Michele D Tisdale, David R Tribble, Indrani Mitra, et al.
Epidemiology and Infection|February 26, 2013
Modifiable diarrhoea risk factors in Egyptian children aged <5 yearsA M Mansour, H El Mohammady, M El Shabrawi, et al.
Gut|July 21, 2026
Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serologyArno R Bourgonje, Gabriel Innocenti, Alexandra Livanos, et al.
Plos One|August 14, 2020
Epidemiology and associated microbiota changes in deployed military personnel at high risk of traveler's diarrheaWilliam A Walters, Faviola Reyes, Giselle M Soto, et al.
Clinical and Vaccine Immunology : CVI|October 11, 2008
Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, TurkeyC K Porter, H El Mohammady, S Baqar, et al.
Plos One|December 2, 2020
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trialKawsar R Talaat, Chad K Porter, Kayla M Jaep, et al.
Gastroenterology|March 14, 2020
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before DiagnosisJoana Torres, Francesca Petralia, Takahiro Sato, et al.
Vaccine|September 26, 2020
A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192GMark S Riddle, Milton Maciel, Chad K Porter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Vaccine|July 27, 2011
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccineMark S Riddle, Robert W Kaminski, Carlos Williams, et al.
Pageof 24